Evidence map›Paper›PMID 29713860›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2018

First time description of early lead failure of the Linox Smart lead compared to other contemporary high-voltage leads.

Vanessa Weberndörfer, Tobias Nyffenegger, Ian Russi, Miriam Brinkert, Benjamin Berte, Stefan Toggweiler, Richard Kobza

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Early Experience with the Biotronik Protego ICD Lead.Journal of clinical medicine · 2022
    Article
  2. Article
  3. Review
  4. Article
  5. Comparison of the performance of implantable cardioverter-defibrillator leads among manufacturers.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vanessa WeberndörferHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland. vanessa.weberndoerfer@luks.ch.ORCID http://orcid.org/0000-0003-2901-6383
Tobias NyffeneggerHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.
Ian RussiHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.
Miriam BrinkertHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.
Benjamin BerteHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.
Stefan ToggweilerHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.
Richard KobzaHeart Center Lucerne, Luzerner Kantonsspital, Lucerne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEarly lead failure has recently been reported in ICD patients with Linox SD leads. We aimed to compare the long-term performance of the following lead model Linox Smart SD with other contemporary high-voltage leads.

methodsAll patients receiving high-voltage leads at our center between November 2009 and May 2017 were retrospectively analyzed. Lead failure was defined as the occurrence of one or more of the following: non-physiological high-rate episodes, low- or high-voltage impedance anomalies, undersensing, or non-capture.

resultsIn total, 220 patients were included (Linox Smart SD, n = 113; contemporary lead, n = 107). During a median follow-up of 3.8 years (IQR 1.6-5.9 years), a total of 16 (14 in Linox Smart SD and 2 in contemporary group) lead failures occurred, mostly due to non-physiological high-rate sensing or impedance abnormalities. Lead failure incidence rates per 100 person-years were 2.9 (95% CI 1.7-4.9) and 0.6 (95% CI 0.1-2.3) for Linox Smart SD compared to contemporary leads respectively. Kaplan Meier estimates of 5-year lead failure rates were 14.0% (95% CI 8.1-23.6%) and 1.3% (95% CI 0.2-8.9%), respectively (log-rank p = 0.028). Implantation of a Linox Smart SD lead increased the risk of lead failure with a hazard ratio (HR) of 4.53 (95% CI 1.03-19.95, p = 0.046) and 4.44 (95% CI 1.00-19.77, p = 0.05) in uni- and multivariable Cox models.

conclusionsThe new Linox Smart SD lead model was associated with high failure rates and should be monitored closely to detect early signs of lead failure.

Indexed as

Defibrillators, ImplantableEquipment FailureEquipment Failure AnalysisAcademic Medical CentersAgedArrhythmias, CardiacCohort StudiesElectrodes, ImplantedEquipment DesignFemaleHumansKaplan-Meier EstimateMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesBiotronikDurataLead failureLinox smartPerformanceSprint Quattro

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.